Dexmedetomidine for sedation in pediatric patients who received more than 20 sessions of radiation therapy -two cases report-

다국어 초록 (Multilingual Abstract)

Dexmedetomidine is a highly selective α2-adrenoceptor agonist that demonstrates anxiolytic and analgesic properties without inducing respiratory compromise, which makes it a suitable agent for procedural sedation and imaging studies. In our current case reports, intravenous dexmedetomidine infusion was used to provide sedation to 2 pediatric patients over more than 20 sessions of radiation therapy. On both occasions, dexmedetomidine provided adequate sedation without respiratory depression. However, the required dosage increased with repeated radiation therapy sessions.

참고문헌 (Reference)

1 Harris EA, "Sedation and anesthesia options for pediatric patients in the radiation oncology suite" 2010 : 870921-, 2010

2 McFadyen JG, "Sedation and anesthesia for the pediatric patient undergoing radiation therapy" 24 : 433-438, 2011

3 Mason KP, "Review article: Dexmedetomidine in children: current knowledge and future applications" 113 : 1129-1142, 2011

4 Buchsbaum JC, "Repetitive pediatric anesthesia in a non-hospital setting" 85 : 1296-1300, 2013

5 "Precedex (Dexmedetomidine) package insert" Hospira, Inc

6 Hartman ME, "Nelson Textbook of Pediatrics" Saunders 489-506, 2016

7 Mason KP, "High dose dexmedetomidine as the sole sedative for pediatric MRI" 18 : 403-411, 2008

8 Mason KP, "Dexmedetomidine for pediatric sedation for computed tomography imaging studies" 103 : 57-62, 2006

9 Shukry M, "Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child" 15 : 241-242, 2005

10 Ramsay MA, "Controlled sedation with alphaxalone-alphadolone" 2 : 656-659, 1974

11 Phan H, "Clinical uses of dexmedetomidine in pediatric patients" 10 : 49-69, 2008